BIRC5 overexpression is associated with mitosis, proliferation, migration, and immune infiltration in different cancers; however, its clinical impacts and associations with the tumor microenvironment (TME) are still not well understood [14,15,16,17,18]. This evidence concerns the gene BIRC5 and cancer.